172 related articles for article (PubMed ID: 23724033)
1. A peptide against soluble guanylyl cyclase α1: a new approach to treating prostate cancer.
Gao S; Hsieh CL; Bhansali M; Kannan A; Shemshedini L
PLoS One; 2013; 8(5):e64189. PubMed ID: 23724033
[TBL] [Abstract][Full Text] [Related]
2. Androgen regulation of soluble guanylyl cyclasealpha1 mediates prostate cancer cell proliferation.
Cai C; Chen SY; Zheng Z; Omwancha J; Lin MF; Balk SP; Shemshedini L
Oncogene; 2007 Mar; 26(11):1606-15. PubMed ID: 16964290
[TBL] [Abstract][Full Text] [Related]
3. Peptide B targets soluble guanylyl cyclase α1 and kills prostate cancer cells.
Zhou J; Gao S; Hsieh CL; Malla M; Shemshedini L
PLoS One; 2017; 12(8):e0184088. PubMed ID: 28859127
[TBL] [Abstract][Full Text] [Related]
4. Soluble guanylyl cyclase α1 and p53 cytoplasmic sequestration and down-regulation in prostate cancer.
Cai C; Hsieh CL; Gao S; Kannan A; Bhansali M; Govardhan K; Dutta R; Shemshedini L
Mol Endocrinol; 2012 Feb; 26(2):292-307. PubMed ID: 22174378
[TBL] [Abstract][Full Text] [Related]
5. COP9 subunits 4 and 5 target soluble guanylyl cyclase α1 and p53 in prostate cancer cells.
Bhansali M; Shemshedini L
Mol Endocrinol; 2014 Jun; 28(6):834-45. PubMed ID: 24725084
[TBL] [Abstract][Full Text] [Related]
6. Elevation of soluble guanylate cyclase suppresses proliferation and survival of human breast cancer cells.
Wen HC; Chuu CP; Chen CY; Shiah SG; Kung HJ; King KL; Su LC; Chang SC; Chang CH
PLoS One; 2015; 10(4):e0125518. PubMed ID: 25928539
[TBL] [Abstract][Full Text] [Related]
7. Gender-specific hypertension and responsiveness to nitric oxide in sGCalpha1 knockout mice.
Buys ES; Sips P; Vermeersch P; Raher MJ; Rogge E; Ichinose F; Dewerchin M; Bloch KD; Janssens S; Brouckaert P
Cardiovasc Res; 2008 Jul; 79(1):179-86. PubMed ID: 18339647
[TBL] [Abstract][Full Text] [Related]
8. Zinc Finger 280B regulates sGCα1 and p53 in prostate cancer cells.
Gao S; Hsieh CL; Zhou J; Shemshedini L
PLoS One; 2013; 8(11):e78766. PubMed ID: 24236047
[TBL] [Abstract][Full Text] [Related]
9. Notch activation augments nitric oxide/soluble guanylyl cyclase signaling in immortalized ovarian surface epithelial cells and ovarian cancer cells.
El-Sehemy A; Chang AC; Azad AK; Gupta N; Xu Z; Steed H; Karsan A; Fu Y
Cell Signal; 2013 Dec; 25(12):2780-7. PubMed ID: 24041655
[TBL] [Abstract][Full Text] [Related]
10. Soluble guanylate cyclase-alpha1 deficiency selectively inhibits the pulmonary vasodilator response to nitric oxide and increases the pulmonary vascular remodeling response to chronic hypoxia.
Vermeersch P; Buys E; Pokreisz P; Marsboom G; Ichinose F; Sips P; Pellens M; Gillijns H; Swinnen M; Graveline A; Collen D; Dewerchin M; Brouckaert P; Bloch KD; Janssens S
Circulation; 2007 Aug; 116(8):936-43. PubMed ID: 17679618
[TBL] [Abstract][Full Text] [Related]
11. Expression of a hyperactive androgen receptor leads to androgen-independent growth of prostate cancer cells.
Hsieh CL; Cai C; Giwa A; Bivins A; Chen SY; Sabry D; Govardhan K; Shemshedini L
J Mol Endocrinol; 2008 Jul; 41(1):13-23. PubMed ID: 18469090
[TBL] [Abstract][Full Text] [Related]
12. Role of the soluble guanylyl cyclase alpha1/alpha2 subunits in the relaxant effect of CO and CORM-2 in murine gastric fundus.
De Backer O; Elinck E; Sips P; Buys E; Brouckaert P; Lefebvre RA
Naunyn Schmiedebergs Arch Pharmacol; 2008 Nov; 378(5):493-502. PubMed ID: 18563392
[TBL] [Abstract][Full Text] [Related]
13. cGMP-independent anti-tumour actions of the inhibitor of soluble guanylyl cyclase, ODQ, in prostate cancer cell lines.
Haramis G; Zhou Z; Pyriochou A; Koutsilieris M; Roussos C; Papapetropoulos A
Br J Pharmacol; 2008 Nov; 155(6):804-13. PubMed ID: 18695639
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide attenuates endothelin-1-induced activation of ERK1/2, PKB, and Pyk2 in vascular smooth muscle cells by a cGMP-dependent pathway.
Bouallegue A; Daou GB; Srivastava AK
Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2072-9. PubMed ID: 17644565
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory phosphorylation of soluble guanylyl cyclase by muscarinic m2 receptors via Gbetagamma-dependent activation of c-Src kinase.
Murthy KS
J Pharmacol Exp Ther; 2008 Apr; 325(1):183-9. PubMed ID: 18180373
[TBL] [Abstract][Full Text] [Related]
16. Erectile Dysfunction in Heme-Deficient Nitric Oxide-Unresponsive Soluble Guanylate Cyclase Knock-In Mice.
Decaluwé K; Pauwels B; Boydens C; Thoonen R; Buys ES; Brouckaert P; Van de Voorde J
J Sex Med; 2017 Feb; 14(2):196-204. PubMed ID: 28161078
[TBL] [Abstract][Full Text] [Related]
17. Soluble guanylate cyclase modulators blunt hyperoxia effects on calcium responses of developing human airway smooth muscle.
Britt RD; Thompson MA; Kuipers I; Stewart A; Vogel ER; Thu J; Martin RJ; Pabelick CM; Prakash YS
Am J Physiol Lung Cell Mol Physiol; 2015 Sep; 309(6):L537-42. PubMed ID: 26254425
[TBL] [Abstract][Full Text] [Related]
18. Receptor-controlled phosphorylation of alpha 1 soluble guanylyl cyclase enhances nitric oxide-dependent cyclic guanosine 5'-monophosphate production in pituitary cells.
Kostic TS; Andric SA; Stojilkovic SS
Mol Endocrinol; 2004 Feb; 18(2):458-70. PubMed ID: 14630997
[TBL] [Abstract][Full Text] [Related]
19. Role of soluble guanylyl cyclase-cyclic GMP signaling in tumor cell proliferation.
Mujoo K; Sharin VG; Martin E; Choi BK; Sloan C; Nikonoff LE; Kots AY; Murad F
Nitric Oxide; 2010 Jan; 22(1):43-50. PubMed ID: 19948239
[TBL] [Abstract][Full Text] [Related]
20. Soluble guanylyl cyclase (sGC) degradation and impairment of nitric oxide-mediated responses in urethra from obese mice: reversal by the sGC activator BAY 60-2770.
Alexandre EC; Leiria LO; Silva FH; Mendes-Silvério CB; Calmasini FB; Davel AP; Mónica FZ; De Nucci G; Antunes E
J Pharmacol Exp Ther; 2014 Apr; 349(1):2-9. PubMed ID: 24421320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
